Advertisement

Topics

Latest Cancer Disease NewsRSS

01:17 EDT 21st September 2017 | BioPortfolio

Dr. William Li Presenting at First International Rethinking Cancer Meeting at European Cancer Centre Gustave Roussy in Paris, France

CAMBRIDGE, Mass., Sept. 20, 2017 /PRNewswire-USNewswire/ -- The Angiogenesis Foundation announced today its President and Medical Director, Dr. William Li, will present new groundbreaking scientific and public health data connecting diet with health and disease, at the first international Rethinking Cancer meeting to be held on 21 September, 2017, at the European Cancer Centre Gustave Ro...

Julie R. Brahmer, MD., MSc is recognized by Continental Who's Who

BALTIMORE, Sept. 20, 2017 /PRNewswire/ -- Julie R. Brahmer, MD., MSc, is recognized by Continental Who's Who among Pinnacle Professionals in the field of Healthcare. Dr. Brahmer is the Co-Director of the Upper Aerodigestive Department within the Bloomberg~Kimmel Institute for Cancer Immunotherapy at Johns Hopkins' Bayview Medical Center. Headquartered in Baltimore, Johns Hopkins Medicine is a...

The big question: Will cancer immune therapy work for me?

Gene tests are starting to help sort out whether immunotherapy will work for individual cancer patients — or whether it might backfire.

Austrian Scientists Listen In on Cancer-Causing Conversations between Stem Cells

A ‘language’ that causes tumors has been identified. This is a big problem for stem cell therapies, so could we now overcome it? Researchers at the Medical University of Vienna, Austria, have spotted conversations between stem cells that controls the ... This awesome article Austrian Scientists Listen In on Cancer-Causing Conversations between Stem Cells appeared first on Labiotech.eu....

OncLive® Presents State of the Science Summit™: Advanced Renal Cell and Bladder Cancer

This State of the Science Summit™ is taking place in partnership with Fox Chase Cancer Center OncLive®, a leading digital provider of resources and information for oncology professionals, announces the latest State of the Science Summit™: Advanced Renal Cell and Bladder Cancer, which will be held at 5:30 p.m. Wednesday, Sept. 27, 2017, at ...

Rapper Offset Launches $500K Fundraising Campaign for the American Cancer Society

ATLANTA, Sept. 20, 2017 /PRNewswire-USNewswire/ -- Rapper Offset, of the chart-topping hip-hop trio Migos, is teaming up with the American Cancer Society and mobilizing his fellow artists, corporate sponsors and passionate fans to raise $500,000 for the organization. Offset's dedication to the fight against cancer is personal. His inspiration for working with the American Cancer Society is hi...

Ignyta to Present at Cantor Fitzgerald 2017 Global Healthcare Conference

Ignyta, Inc. (Nasdaq: RXDX), a biotechnology company focused on precision medicine in oncology, announced today that Jacob Chacko, M.D., its Chief Financial Officer, will make a presentation at the Cantor Fitzgerald 2017 Global Healthcare Conference on Wednesday, September 27, 2017, at 1:05 p.m. Eastern time (10:05 a.m. Pacific time) in New York, NY. ...

New UK Team will develop Next-Generation Antibody-Drug Conjugates for Cancer

Glythera and IONTAS have partnered to develop next-generation antibody-drug conjugates that are less toxic and more potent against difficult-to-treat tumors. Glythera has teamed up with antibody developer IONTAS to work on a new generation of antibody-drug conjugate (ADC) drugs. As part of the agreement, IONTAS ... This awesome article New UK Team will develop Next-Generation Antibody-Drug Co...

Dutch Biotech Gets Special Designation for Reduced Risk Blood Cancer Treatment

The FDA has backed Kiadis Pharma’s lead blood cancer product by granting it the Regenerative Medicine Advanced Therapy designation. Kiadis Pharma, based in Amsterdam, develops products to make bone marrow transplants for the treatment of blood cancer and inherited blood disorders safer ... This awesome article Dutch Biotech Gets Special Designation for Reduced Risk Blood Cancer Treatment a...

Dr. Michael Lazar on September’s Prostate Cancer Awareness Campaign; Why Early Detection Saves Lives

Santa Rosa urologist and prostate cancer expert Dr. Michael Lazar provides an overview of prostate cancer screening options, and offers insight on a new study suggesting that early detection saves lives. Santa Rosa, CA (PRWEB) September 20, 2017 September is Prostate Cancer Awareness Month helping to put the spotlight on a very important topic; early treatment options. Second only to skin cancer,...

West Dermatology & Skin Cancer Center to Have Grand Opening in San Diego, CA

Mark your calendars for September 21, 2017, the grand opening of this brand new innovative skin cancer treatment and research center. San Diego, CA (PRWEB) September 20, 2017 West Dermatology, the foremost network of dermatology and skin cancer centers in the southwest United States, is proud to announce the grand opening of the West Dermatology & Skin Cancer Center in San Diego, CA. This new...

Hyundai Hope On Wheels Awards $150,000 Research Grant To Helen Devos Children's Hospital In Honor Of National Childhood Cancer Awareness Month

GRAND RAPIDS, Mich., Sept. 20, 2017 /PRNewswire/ -- Hyundai Hope On Wheels® will today present Helen DeVos Children's Hospital with a $150,000 Hyundai Young Investigator Grant. The grant funds will support the research of principal investigator Dr. Jenna Gedminas. This award is part of the organization's efforts during National Childhood Cancer Awareness Month.  In September alone,...

Altering Tumor Microenvironment May Offer New Approach to Metastatic Melanoma Therapy

Researchers at the Wistar Institute and the Medical University of Vienna say they have identified the role of tumor-infiltrating or tumor-associated B-cells (TABs) in melanoma progression and resistance to targeted therapy. A molecular mechanism that governs the interactions between TABs and tumor cells has now been clarified and this could lead to a potential new therapeutic strategy for combatin...

PharmaMar Starts Clinical Studies with a New Compound -PM14- in Patients with Solid Tumors

MADRID, September 20, 2017 /PRNewswire/ -- With the motivation of finding a solution to the unmet needs of patients with different types of cancer, PharmaMar (MCE:PHM) announces the start of a Phase I clinical study with PM14, a new antitumor compound resulting from the company´s internal investigation program for the treatment of patients with advanced solid tumors.    &nb...

Lung Cancer Asbestos Victims Center Now Urges a Navy Veteran or Industrial Worker with Lung Cancer to Call Them About Possible Compensation If They Had Workplace Exposure to Asbestos

NEW YORK, Sept. 20, 2017 /PRNewswire/ -- The Lung Cancer Asbestos Victims Center is now urging a US Navy Veteran, or an industrial worker in any state who has recently been diagnosed with lung cancer to call them, if they were exposed to asbestos on a US Navy ship, or at an industrial workplace, because there could be significant financial compensation for these specific types&...

In Congress, a doctor becomes a cancer patient — and preaches candor

Rep. Phil Roe, a Tennessee Republican, speaks with candor and objectivity about the trials — and the surprising moments of joy — that came with a diagnosis.

Syndax Pharmaceuticals Announces Updated Presentation Time at the Cantor Fitzgerald Global Healthcare Conference

WALTHAM, Mass., Sept. 20, 2017 /PRNewswire/ -- Syndax Pharmaceuticals, Inc. (Nasdaq:SNDX), a clinical stage biopharmaceutical company developing entinostat and SNDX-6352 in multiple cancer indications, today announced an update to the time of the Company's presentation at the Cantor Fitzgerald Global Healthcare Conference. Briggs W. Morrison, M.D., Chief Executive Officer of Syndax, will now ...

Cancer Horizons Forms an Alliance With Lexli International Inc. to Make Skin-Care Products Available Free to Cancer Patients, Launches Compassionate Cancer Patient Resources™ Program

SALT LAKE CITY, Sept. 20, 2017 /PRNewswire/ -- Cancer Horizons, the premier online portal exclusively for cancer patients, announced today that it has formed an alliance with Lexli International, Inc., noted developer of a leading line of aloe-based skin care products, to provide exclusively to those battling cancer a generous 4-oz. bottle of Lexli's aloe-based Hand & Body Lotion FREE of ...

Ramucirumab for Advanced Urothelial Cancer

Adding the IgG1 monoclonal antibody ramucirumab to docetaxel improved progression-free survival at 5-month follow-up.

XBiotech Announces Agreement with Cedars-Sinai Medical Center to Evaluate MABp1 in Combination with OnivydeⓇ and 5-fluorouracil/folinic acid for the Treatment of Pancreatic Cancer

AUSTIN, Texas, Sept. 20, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today its agreement with Cedars-Sinai Medical Center located in Los Angeles, California, whereby XBiotech will provide its interleukin-1 alpha antagonist, MABp1, for a Phase I single arm study evaluating the maximum tolerated dose of OnivydeⓇ (Irinotecan liposome injection) and 5-fluorouracil/folinic aci...

Eli Lilly Heads to Finish Line with Breast Cancer Treatment Abemaciclib

Soligenix Announces $1.5 Million SBIR Grant Award Supporting The Pivotal Phase III Clinical Trial Of SGX942 For The Treatment Of Oral Mucositis In Head And Neck Cancer

  Life Sciences Jobs   ...

Hearst Invests In H. Lee Moffitt Cancer Center & Research Institute Subsidiary M2Gen

  Life Sciences Jobs   ...

Edinburgh Molecular Imaging Commences Phase II European Cancer Trial

  Life Sciences Jobs   ...

The And The Announce First Patients Treated In Pancreatic Cancer Clinical Trial Combining Immunotherapy And Chemotherapy

  Life Sciences Jobs   ...

Quick Search
Advertisement
 

review and buy Cancer Disease market research data and corporate reports here